Cookie Consent by FreePrivacyPolicy.com
genekam logo
  • usa
    • german
    • russia
    • china
Duissernstr. 65a · 47058 Duisburg · Germany
Tel. +49 203 / 555 858 -31 / 32 / 33 · Fax: +49 203 / 35 82 99
menuicon
slider
Latest News:

08.10.2021
Genekam developed a powermolecule against SARS CoV-2 and other corona viruses for their prevention!

Latest News:

15.04.2021
Genekam has developed
ultrasensitive Magnetic beads ELISA for SARS CoV-2

  • ++Merry Christmas and happy new Year 2022++

    we are closed until 6th. January 2022.

  • ++BREAKING NEWS (26.05.2020)++

    Plasma therapy accelerator (SARS-Hunter): a new solution for better antibody therapy for all coronavirus patients.

  • MEDICA 2022

    Visit us at MEDICA in Duesseldorf, Germany:
    November 2022

Antibody Conjugate Therapy

Genekam is developing complex solutions based on antibody conjugates for therapeutic and diagnostic use. The antibodies can be recombinant as well as monoclonal type. Conjugates will be based on beyond the state of art technology. Some of conjugates may have potential to be used as vaccines also.

TOP